Nexim

ICASA: Conference will strengthen; invest in Africa to manufacture vaccines – Idoko

2 weeks ago | 104



NCC
ExxonMobil

Prof. John Idoko, the President, 2021 International Conference on AIDS and STIs in Africa (ICASA) says the forthcoming conference will focus on strengthening and investing in Africa’s scientific capacity to manufacture vaccines.

Idoko, who made this known in an interview with the News Agency of Nigeria (NAN) on Wednesday in Abuja, said the conference would start from Dec. 6 to Dec. 11, in Durban, South Africa.

“The theme of the 2021 ICASA is: Africa AIDS response: The race to 2030 – Evidence. Scale-up. Accelerates’’.

He said the focus of the conference would be to strengthen health systems to integrate high impact interventions on comorbidities, emerging infections and Non-Communicable Diseases (NCDs).

“It is also to build, strengthen and invest in Africa’s scientific capacity and manufacturing of vaccines, diagnostics and therapeutics.

“And to identify in Africa’s resource tailored interventions, for populations most affected, including women, children, adolescents, men and key populations,’’ he said.

The ICASA President said that the conference would also evaluate the impact of COVID-19 on the HIV and AIDS’ response and share lessons learned in overcoming barriers in
maintaining continuity of care for people living with and at risk in contracting HIV.

According to him, the 2019 conference in Kigali, Rwanda had almost 9,000 delegates and the 2021 conference will witness fewer participants due to the COVID-19 pandemic.

He said that the aim of the conference was to host 3,000 persons physically, while the rest of the delegates would join virtually.

Idoko said that the conference would also discuss measures aimed at ending HIV and AIDS, among other diseases.

“There is need to examine the effect of COVID-19 on people living with HIV and AIDS.

“The COVID-19 pandemic has disrupted the provision of life saving services to vulnerable communities and increased infections.

“People living with HIV, who contracted the COVID-19, found it difficult to manage the two condit,ions,’’ The ICASA President noted. (NAN) 

- Nov. 24, 2021 @ 12:32 GMT |

Readers Comments

0 comment

No comments yet. Be the first to post comment.

Related stories

Recommended for you...

From Twitter